Shares of Macy’s, Inc. (NYSE: M) were down over 2% on Tuesday. The stock has dropped 25% year-to-date. The retailer is scheduled to report its second quarter 2023 earnings results on Tuesday, August 22, before market open. Here’s a look at what to expect from the earnings report:
Revenue
Macy’s has guided for net sales of $5.0-5.1 billion for the second quarter of 2023. Analysts are projecting revenue of $5.09 billion for Q2, which would represent a decline of 9% from the same period a year ago. In the first quarter of 2023, net sales declined 7% year-over-year to $5 billion.
Earnings
Macy’s has guided for adjusted EPS of $0.10-0.15 for Q2 2023. Analysts are forecasting EPS of $0.13 for Q2 which compares to $1.00 reported in the year-ago period. In Q1 2023, adjusted EPS fell to $0.56 from $1.08 in the prior-year period.
Points to note
Macy’s continues to be pressured by a challenging economic environment and shifts in consumer spending. Demand for discretionary categories weakened as customers moved their spending to food and essentials. Comparable sales fell 7.9% on an owned basis and 7.2% on an owned-plus-licensed basis. These pressures are expected to continue in the second quarter.
Gross margin in Q1 rose to 40% from 39.6% in the year-ago period. Merchandise margin remained flat, benefiting from lower clearance markdowns. In the second quarter, the company plans to implement deeper markdowns to clear its excess inventory, which is expected to lead to a drop in gross margin.
Macy’s is expected to benefit from its investments in private brands, small-format stores and Macy’s Marketplace. The company is seeing encouraging results from its small-format stores and remains optimistic about the opportunity in this space.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was